Watson Pharma (WPI) Affirms Delaware Court of Appeals Ruling that Sanctura XR Patents are Invalid
Go back to Watson Pharma (WPI) Affirms Delaware Court of Appeals Ruling that Sanctura XR Patents are Invalid| Watson Pharmaceuticals, Inc. (NYSE: WPI) | Delayed: 85.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.73 | 52 Week High | $91.47 | |||
| Open | $16.30 | 52 Week Low | $57.16 | |||
| Day High | $85.73 | P/E | 66.46 | |||
| Day Low | $85.73 | EPS | $1.29 | |||
| Volume | 3,625 | |||||
